These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


622 related items for PubMed ID: 17890232

  • 1. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.
    Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC, 4-T Study Group.
    N Engl J Med; 2007 Oct 25; 357(17):1716-30. PubMed ID: 17890232
    [Abstract] [Full Text] [Related]

  • 2. Three-year efficacy of complex insulin regimens in type 2 diabetes.
    Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK, 4-T Study Group.
    N Engl J Med; 2009 Oct 29; 361(18):1736-47. PubMed ID: 19850703
    [Abstract] [Full Text] [Related]

  • 3. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.
    Clin Ther; 2007 Nov 29; 29(11):2374-84. PubMed ID: 18158078
    [Abstract] [Full Text] [Related]

  • 4. Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes.
    Farmer AJ, Oke J, Stevens R, Holman RR.
    Diabetes Obes Metab; 2011 Dec 29; 13(12):1136-41. PubMed ID: 21767341
    [Abstract] [Full Text] [Related]

  • 5. Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride.
    Kann PH, Wascher T, Zackova V, Moeller J, Medding J, Szocs A, Mokan M, Mrevlje F, Regulski M.
    Exp Clin Endocrinol Diabetes; 2006 Oct 29; 114(9):527-32. PubMed ID: 17115351
    [Abstract] [Full Text] [Related]

  • 6. Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial.
    Lundby-Christensen L, Vaag A, Tarnow L, Almdal TP, Lund SS, Wetterslev J, Gluud C, Boesgaard TW, Wiinberg N, Perrild H, Krarup T, Snorgaard O, Gade-Rasmussen B, Thorsteinsson B, Røder M, Mathiesen ER, Jensen T, Vestergaard H, Hedetoft C, Breum L, Duun E, Sneppen SB, Pedersen O, Hemmingsen B, Carstensen B, Madsbad S.
    BMJ Open; 2016 Feb 25; 6(2):e008377. PubMed ID: 26916685
    [Abstract] [Full Text] [Related]

  • 7. Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial.
    Liebl A, Prager R, Binz K, Kaiser M, Bergenstal R, Gallwitz B, PREFER Study Group.
    Diabetes Obes Metab; 2009 Jan 25; 11(1):45-52. PubMed ID: 18643839
    [Abstract] [Full Text] [Related]

  • 8. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.
    Ann Intern Med; 2008 Oct 21; 149(8):531-9. PubMed ID: 18936501
    [Abstract] [Full Text] [Related]

  • 9. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL, Kerr L, Malone JK, Tan MH.
    Clin Ther; 2007 Jun 21; 29(6 Pt 1):1254-70. PubMed ID: 18036388
    [Abstract] [Full Text] [Related]

  • 10. A comparison of twice-daily biphasic insulin aspart 70/30 and once-daily insulin glargine in persons with type 2 diabetes mellitus inadequately controlled on basal insulin and oral therapy: a randomized, open-label study.
    Ligthelm RJ, Gylvin T, DeLuzio T, Raskin P.
    Endocr Pract; 2011 Jun 21; 17(1):41-50. PubMed ID: 20713345
    [Abstract] [Full Text] [Related]

  • 11. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
    Hollander P, Cooper J, Bregnhøj J, Pedersen CB.
    Clin Ther; 2008 Nov 21; 30(11):1976-87. PubMed ID: 19108786
    [Abstract] [Full Text] [Related]

  • 12. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.
    Clin Ther; 2007 Nov 21; 29(11):2349-64. PubMed ID: 18158076
    [Abstract] [Full Text] [Related]

  • 13. Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections.
    Riddle MC, Rosenstock J, Vlajnic A, Gao L.
    Diabetes Obes Metab; 2014 May 21; 16(5):396-402. PubMed ID: 24118931
    [Abstract] [Full Text] [Related]

  • 14. Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape).
    Vora J, Cohen N, Evans M, Hockey A, Speight J, Whately-Smith C.
    Diabetes Obes Metab; 2015 Dec 21; 17(12):1133-41. PubMed ID: 26085028
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial.
    Lundby Christensen L, Almdal T, Boesgaard T, Breum L, Dunn E, Gade-Rasmussen B, Gluud C, Hedetoft C, Jarloev A, Jensen T, Krarup T, Johansen LB, Lund SS, Madsbad S, Mathiesen E, Moelvig J, Nielsen F, Perrild H, Pedersen O, Roeder M, Sneppen SB, Snorgaard O, Tarnow L, Thorsteinsson B, Vaag A, Vestergaard H, Wetterslev J, Wiinberg N, CIMT Trial Group.
    Diabetes Obes Metab; 2009 Apr 21; 11(4):315-22. PubMed ID: 19267709
    [Abstract] [Full Text] [Related]

  • 18. Comparison of thrice daily biphasic human insulin (30/70) versus basal detemir & bolus aspart in patients with poorly controlled type 2 diabetes mellitus - a pilot study.
    Shanmugasundar G, Bhansali A, Walia R, Dutta P, Upreti V.
    Indian J Med Res; 2012 Apr 21; 135(1):78-83. PubMed ID: 22382187
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of once-daily glargine plus sulfonylurea with twice-daily 70/30 aspart premix in insulin-naive Japanese patients with diabetes.
    Tamemoto H, Ikoma A, Saitoh T, Ishikawa SE, Kawakami M.
    Diabetes Technol Ther; 2007 Jun 21; 9(3):246-53. PubMed ID: 17561795
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.